Flexible formats for an array of indications
Fuelled by the Nebula Antibody Platform, Immune Biosolutions’ therapeutic pipeline encompasses candidates that tackle a wide variety of diseases spanning from opportunistic infections to cancer, and cover areas such as inflammation, pain and gastrointestinal health.
To solve world health issues
Antibodies have the potential to serve in a plethora of indications. Immune Biosolutions’ internal pipeline has three main focal points. First, gastrointestinal health, namely indications that can be tackled by orally-administered immunotherapy. Second, disease areas involving GPCRs and other membrane proteins, especially those for which the therapeutic need is unmet. Third, is antibody development, engineering and tailoring based on collaborations with strategic partners.
Therapeutic antibody candidates
Many applications, twin focus
Immune Biosolutions’ pipeline covers a wide range of applications. The main therapeutic fields encompass cancer and gastrointestinal health.
Therapeutic candidate licenses
Licensing opportunities are available for many pipeline candidates. Specific agreements can be made in regards to applications and milestones.
Therapeutic antibody development
For projects involving de novo raising of recombinant antibodies, additional agreements can be included at different levels to cover the generated intellectual property.